EuroNoxx Medical Group Secures UK Distributorship for Koning Vera Breast CT with Koning Corporation

LONDON - Aug. 14, 2024 - PRLog -- EuroNoxx Medical Group and Koning Corporation (USA) are delighted to announce an exclusive partnership to bring the Koning Vera Breast CT to the United Kingdom. This agreement marks a major stride forward in advancing breast cancer diagnostics across the UK.

The Koning Vera Breast CT, now registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA), is an innovative imaging system offering unparalleled 3D breast imaging with extraordinary clarity and detail—without uncomfortable compression. This breakthrough technology presents a more accurate and patient-friendly alternative to traditional mammography, poised to revolutionise early breast cancer detection and diagnosis.

Join Us at the Breast Cancer 2024 Symposium

To honour this achievement, EuroNoxx Medical Group, in collaboration with Koning Corporation, the London International Medical School, and Allengers, will host the Breast Cancer 2024 Symposium. As a principal organiser and sponsor, we invite healthcare professionals and industry leaders to explore the future of breast cancer care.

This symposium will highlight the latest innovations in breast cancer diagnostics, focusing on the Koning Vera Breast CT. Attendees will gain insights from renowned experts, engage in thought-provoking panel discussions, and explore the future of breast cancer detection.

Dr. Mandeep Goma, Managing Director of EuroNoxx Medical Group, expressed his enthusiasm, stating, "Securing this exclusive distributorship with Koning Corporation marks a pivotal moment for breast cancer care in the UK. The Breast Cancer 2024 Symposium will be a vital platform for fostering dialogue on advancements in breast cancer diagnostics, and we are honoured to be at the forefront of these transformative discussions."

Lutao Ning, CEO of Koning Corporation, remarked, "Our partnership with EuroNoxx Medical Group  enables us to introduce the Koning Vera Breast CT to the UK market, fulfilling our mission to enhance breast cancer detection and patient care globally. We eagerly anticipate presenting this cutting-edge technology to the UK's medical community."

Event Details:

- Date: Saturday, 7 September 2024
- Time: 9:00 am - 5:00 pm
- Venue: Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE
- Contact: +44 20 3642 1175 | symposium24@euronoxxmedical.com

This symposium is set to be a pivotal event for professionals and stakeholders committed to advancing breast cancer care.

For further information about the distributorship agreement and symposium, please contact EuroNoxx Medical Group Ltd at symposium24@euronoxxmedical.com.

About EuroNoxx Medical Group Ltd:

EuroNoxx Medical Group Ltd is at the forefront of enhancing healthcare in the UK through cutting-edge medical solutions for the NHS and private hospitals. By leveraging strategic partnerships and innovative technologies, we strive to elevate the standard of healthcare delivery.

Media Contact:

Ed Beasley
Digital Marketing Manager
EuroNoxx Medical Group Ltd
Contact: +44 20 3642 1175 | info@euronoxxmedical.com | www.euronoxxmedical.com